doxycycline

Recent Rosacea Blog Posts

Minocycline 100mg is better than Oracea

A study just published in the British Journal of Dermatology has shown that Minocycline 100mg a day is as good, and by some measures is a better treatment for the papules and pustules of rosacea compared to the 40mg a day  doxyxcycline treatment Oracea. Minocycline as a treatment for rosacea is relatively unknown, with a lack […]

Continue Reading

Zenavod (DFD-09) is the new Generic Oracea – sadly no

News today that Dr. Reddy’s subsidiary Promius Pharma has gained tentative approval for their 40mg formulation of doxycycline for the papules and pustles of rosacea. Before we get too excited about the real possibility of the availability of a generic form of Oracea, the announcement tells us that the approval is “subject to an automatic […]

Continue Reading

Patent reveals possible Oracea successor

A patent application has emerged that proposed what might be an improvement to the doxycycline based Oracea treatment for rosacea. The patent seeks to create a sub-antibiotic dose formulation of doxycycline that is less susceptible to what it calls the `food effect’. Food effect refers to food-drug interactions which lead to either a decrease or […]

Continue Reading

Say goodbye to Generic Oracea

A recent ruling from the U.S. Patent and Trademark Office has put the final nail in coffin of the hopes for the availability of Generic Oracea. Rosacea sufferers will need to wait until that late 2020’s until the current patents protecting Oracea expire. Concerted efforts from Amneal Pharmaceuticals and Mylan Inc. have both failed to […]

Continue Reading

Oracea available as Efracea (now Apprilon) in Canada

This seems to have gone mostly unnoticed by rosacea sufferers, but in early 2012 Health Canada approved Efracea as a treatment for the papules and pustules of rosacea. Called a Summary Basis of Decision for Efracea, Health Canada decreed: Summary Basis of Decision (SBD) for EFRACEA EFRACEA Doxycycline monohydrate, 40 mg capsule Galderma Canada Inc. […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.